Mammary Cancer in Dogs and Cats: Prevention Through Spaying

Mammary tumours are the most frequently diagnosed neoplasm in intact (unspayed) female dogs, representing approximately 42 per cent of all tumours in this group. In cats, mammary cancer is the third most common tumour overall, following lymphoma and skin cancer. These statistics carry an important subtext: the overwhelming majority of mammary tumours occur in pets that have not been spayed, or that were spayed later in life after multiple heat cycles.

"The link between reproductive hormones and mammary cancer in pets is one of the strongest cause-and-effect relationships in veterinary oncology. Spaying before the first heat cycle is one of the single most impactful preventive health decisions a pet owner can make." — Dr. Sarah Chen, DVM

In dogs, the average age at diagnosis is 10 to 12 years, though tumours can appear as early as five or six in predisposed breeds. In cats, the average age is slightly older — around 10 to 14 years. Certain dog breeds face higher risk, including Springer Spaniels, English Setters, German Shepherds, Pointers, and Poodles. Siamese cats have approximately twice the risk of other breeds. Understanding how common mammary cancer is — and how preventable it can be — underscores the importance of following a preventative care schedule that includes early spaying discussions with your veterinarian.

Male dogs and cats can also develop mammary tumours, though this is extremely rare and usually associated with hormonal imbalances or conditions such as Sertoli cell tumours in intact males.

The relationship between spaying age and mammary cancer risk is supported by decades of research, and the numbers are striking. In dogs, spaying before the first oestrus (heat) cycle — typically around six months of age — reduces the risk of developing mammary tumours to just 0.5 per cent compared to intact females. Spaying after the first heat but before the second raises the risk to approximately 8 per cent. After the second heat, the risk climbs to around 26 per cent. After two and a half years of age, the protective benefit of spaying against mammary cancer diminishes significantly, though spaying at any age still offers some benefit by removing the ongoing hormonal stimulation.

In cats, the protective effect is equally dramatic. Spaying before six months of age reduces mammary cancer risk by 91 per cent. Spaying before one year reduces it by 86 per cent. Even spaying between one and two years still provides a significant reduction of around 11 per cent compared to intact cats. Given that 85 to 90 per cent of mammary tumours in cats are malignant — compared to roughly 50 per cent in dogs — the case for early spaying in cats is particularly compelling.

The biological mechanism is well understood. Mammary tissue development is driven by oestrogen and progesterone during each heat cycle. With each cycle, the mammary glands undergo proliferation and remodelling, creating more opportunities for the genetic mutations that lead to cancer. Removing the ovaries (and thus the primary source of these hormones) before this repeated stimulation occurs dramatically reduces the likelihood of malignant transformation.

It is worth noting that spaying later in life, while less protective against mammary cancer specifically, still offers numerous health benefits including eliminating the risk of pyometra (a potentially fatal uterine infection) and ovarian cancer. The decision of when to spay should be made in consultation with your veterinarian, considering your pet's breed, size, and individual health factors.

Mammary tumours typically present as one or more firm lumps within or beneath the mammary glands, which run in two parallel chains along the underside of the abdomen from the chest to the groin. Dogs have five pairs of mammary glands while cats have four pairs, and tumours can develop in any of them — though the two glands closest to the hind legs are most commonly affected in both species.

Early mammary tumours may be small — sometimes as small as a pea — and feel like a firm, movable nodule under the skin. They are usually painless initially, which is why they can go unnoticed until they grow larger. As tumours progress, they may become fixed to underlying tissue, grow rapidly, ulcerate through the skin surface, or produce a bloody or purulent discharge. The overlying skin may become red, warm, or thickened.

In advanced cases, pet owners may notice more systemic signs: weight loss, decreased appetite, lethargy, difficulty breathing (if the cancer has spread to the lungs), or signs of pain such as reluctance to lie on the abdomen, licking at the mammary area, or behavioural changes. Inflammatory mammary carcinoma — a particularly aggressive variant — can cause rapid, diffuse swelling of the entire mammary chain with warmth and pain, sometimes mimicking mastitis (mammary gland infection).

The key takeaway for pet owners: make a habit of gently feeling along your pet's mammary chain during belly rubs or grooming sessions. Any new lump, no matter how small, should be examined by your vet within one to two weeks. Early detection dramatically improves treatment outcomes for mammary cancer.

One of the most critical differences between mammary tumours in dogs and cats lies in the malignancy rate. In dogs, approximately 50 per cent of mammary tumours are benign — typically fibroadenomas, simple adenomas, or mixed mammary tumours that do not spread. The other 50 per cent are malignant, including carcinomas, sarcomas, and carcinosarcomas with varying degrees of aggressiveness.

In cats, the picture is starkly different. Between 85 and 90 per cent of feline mammary tumours are malignant, and they tend to behave aggressively — growing rapidly, invading surrounding tissue, and metastasising early to regional lymph nodes, lungs, and abdominal organs. Even small feline mammary tumours (under 2 cm) carry a significant risk of metastasis, making prompt diagnosis and aggressive treatment essential.

In dogs, the size of the tumour at the time of surgery is one of the strongest prognostic indicators. Tumours under 3 cm have a significantly better prognosis than those over 5 cm. The histological type also matters — simple carcinomas generally carry a better prognosis than complex carcinomas or sarcomas. Inflammatory mammary carcinoma in either species carries the worst prognosis, with median survival times of weeks to months even with treatment.

Because benign and malignant mammary tumours cannot be reliably distinguished by physical examination alone — even by experienced veterinarians — biopsy and histopathological evaluation are always recommended. A lump that feels small, smooth, and mobile could still be malignant, while a larger, irregular mass might turn out to be benign. Never assume based on appearance alone.

Diagnosing mammary cancer begins with a thorough physical examination, during which your vet will palpate all mammary glands (tumours are frequently multiple) and assess regional lymph nodes. A fine needle aspirate (FNA) may be attempted, though mammary tumours can be difficult to diagnose definitively via FNA alone due to their mixed cellular composition. The gold standard is a tissue biopsy — either an incisional biopsy of a large mass or excisional biopsy where the tumour is removed and submitted for histopathology.

Staging is essential to determine whether the cancer has spread and to guide treatment planning. Standard staging includes three-view chest X-rays (the lungs are the most common site of metastasis), abdominal ultrasound to evaluate abdominal lymph nodes and organs, and complete blood work. Fine needle aspirates of enlarged regional lymph nodes help determine if tumour cells have reached the lymphatic system. Advanced imaging such as CT scans may be recommended for large or aggressive tumours to better define the extent of disease.

Regular veterinary check-ups are crucial for catching mammary tumours early. During routine wellness visits, your vet should palpate the mammary chain — especially in intact or late-spayed females. For high-risk patients, some oncologists recommend mammary ultrasound as a screening tool, though this is not yet standard practice.

The TNM (Tumour, Node, Metastasis) staging system used for mammary tumours classifies the cancer from Stage I (small tumour, no lymph node involvement, no distant spread) to Stage IV (any size tumour with distant metastasis). Staging provides a common language for your veterinary team to discuss prognosis and helps you understand what to expect from treatment.

Surgery is the cornerstone of mammary cancer treatment in both dogs and cats. In dogs, the surgical approach depends on the number and location of tumours — options range from lumpectomy (removal of a single mass) to regional mastectomy (removal of several adjacent glands) to radical mastectomy (removal of the entire mammary chain on one side). In cats, aggressive surgery is generally recommended due to the high malignancy rate — a unilateral or bilateral mastectomy with wide margins offers the best chance of local control.

For malignant tumours with unfavourable histopathology, high mitotic index, or evidence of lymph node involvement, adjuvant chemotherapy is typically recommended. Common protocols include doxorubicin or carboplatin, administered every three weeks for four to six cycles. While chemotherapy cannot cure metastatic disease, it can slow progression and improve quality of life. Hormonal therapy, which is a mainstay of breast cancer treatment in humans, has limited evidence of efficacy in pets, though research is ongoing.

Prognosis varies widely. Dogs with small, low-grade tumours that are completely excised can live normal lifespans. Dogs with large, high-grade, or metastatic tumours face median survival times of six to twelve months. In cats, even with aggressive surgery, recurrence rates are high — cats with tumours under 2 cm have a median survival of around three years, while those with tumours over 3 cm survive a median of four to six months.

The most powerful message in mammary oncology is prevention. Spaying your dog before her first heat or your cat before six months of age virtually eliminates mammary cancer risk. For pets that are already intact and older, spaying still provides benefit by halting further hormonal stimulation — and monthly mammary checks at home become essential for early detection. Prevention is always better than treatment, and this is one cancer where prevention is remarkably effective.